Provided by Tiger Trade Technology Pte. Ltd.

Collegium Pharmaceutical

27.11
-0.4300-1.56%
Post-market: 27.110.00000.00%19:30 EDT
Volume:704.93K
Turnover:19.13M
Market Cap:882.58M
PE:21.35
High:27.68
Open:27.68
Low:26.96
Close:27.54
52wk High:50.79
52wk Low:25.47
Shares:32.56M
Float Shares:31.37M
Volume Ratio:0.94
T/O Rate:2.25%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.27
EPS(LYR):1.73
ROE:17.61%
ROA:5.75%
PB:2.83
PE(LYR):15.67

Loading ...

Is Collegium Pharmaceutical (COLL) A Bargain On Its Azstarys Deal And 2026 Guidance?

Simply Wall St.
·
Jul 04

Collegium Amends 8-K to Add Corium Therapeutics Audited Financial Statements

Reuters
·
Jul 01

Did Collegium Pharmaceutical’s Profitability Surge and Efficiency Gains Just Shift COLL’s Investment Narrative?

Simply Wall St.
·
Jun 21

Collegium Pharmaceutical awards 50,305 RSUs to 34 newly hired employees under inducement plan

Reuters
·
Jun 05

Collegium Pharmaceutical Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Jun 05

Collegium Pharma director John Gordon Freund sells 20 shares for $681

Reuters
·
May 21

Collegium director John Gordon Freund disposes 4,127 shares for $142,557.58

Reuters
·
May 19

Collegium Pharma director Michael Donovan files initial beneficial ownership statement

Reuters
·
May 19

Collegium Pharmaceutical shareholders elect eight directors at annual meeting

Reuters
·
May 16

Collegium Pharma director Nancy Lurker disposes 4,500 shares for $161,861.06

Reuters
·
May 16

Collegium Pharmaceutical Rocked by Eye-Catching Insider Stock Move

TIPRANKS
·
May 14

Collegium Pharma director Garen G. Bohlin disposes 8,700 shares for $323,493.23

Reuters
·
May 14

Barclays Keeps Their Buy Rating on Collegium Pharmaceutical (COLL)

TIPRANKS
·
May 13

BRIEF-Collegium Completes Acquisition Of Azstarys® From Corium Therapeutics

Reuters
·
May 12

Collegium Pharmaceutical Completes AZSTARYS ADHD Business Acquisition

TIPRANKS
·
May 12

Collegium Pharmaceutical Completes Azstarys Acquisition, Raises 2026 Net Product Revenue Guidance

MT Newswires Live
·
May 12

Collegium raises 2026 net product revenue outlook to $865-$895 million

Reuters
·
May 12

Collegium Completes Acquisition of Azstarys® From Corium Therapeutics

THOMSON REUTERS
·
May 12

Press Release: Collegium Completes Acquisition of AZSTARYS(R) from Corium Therapeutics

Dow Jones
·
May 12

Stock Track | Collegium Pharmaceutical Soars 8.46% in Pre-market on Strong Q1 Results and Guidance Reaffirmation

Stock Track
·
May 07